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The influence of the oxidative state of chylomicron remnants (CMR) on the mechanisms of their uptake and induction of lipid accumulation by
macrophages derived from the human monocyte cell line, THP-1, during foam cell formation was investigated using chylomicron-remnant-like
particles (CRLPs) at 3 different levels of oxidation. The oxidative state of CRLPs was varied by exposure to CuSO4 (oxCRLPs) or incorporation
of the antioxidant, probucol (pCRLPs) into the particles. oxCRLPs caused significantly less accumulation of triacylglycerol in the macrophages
than CRLPs, and their rate of uptake was lower, while pCRLPs caused more lipid accumulation and were taken up faster. Uptake of all 3 types of
particles was inhibited to a similar extent when entry via the low density lipoprotein (LDL) receptor related protein (80–90%), LDL receptor
(−30–40%), CD36 (−40%) and phagocytosis (−35–40%) was blocked using lactoferrin, excess LDL, anti-CD36 and cytochalasin D,
respectively, but blocking scavenger receptors-A or -B1 using poly inosinic acid or excess HDL had no effect. These findings show that oxidation
of CRLPs lowers their rate of uptake and induction of lipid accumulation in macrophages. However, oxidation does not change the main pathways
of internalisation of CRLPs into THP-1 macrophages, which occur mainly via the LRP with some contribution from the LDLr, while CD36 and
phagocytosis have only a minor role, regardless of the oxidative state of the particles. Thus, the effects of CMR oxidation on foam cell formation
contrast sharply with those of LDL oxidation and this may be important in the role of dietary oxidized lipids and antioxidants in modulating
atherosclerosis.
© 2007 Elsevier B.V. Open access under CC BY-NC-ND license.Keywords: Chylomicron remnants; Foam cells; Oxidized lipoproteins; Macrophages; Atherosclerosis1. Introduction
Chylomicron remnants (CMR) carry lipids of dietary origin
from the gut to the liver for processing [1] and there is now a
large and growing body of evidence indicating that these
lipoproteins are strongly atherogenic. They have been shown to
be taken up into the artery wall as efficiently as LDL [2–5];
remnant-like particles containing apolipoprotein E (apoE) have
been isolated from human aortic intima and atherosclerotic
plaque [6,7]; and delayed clearance of CMR from the
circulation correlates with lesion development [8,9]. Moreover,
we and others have shown that CMR induce extensive lipid
accumulation causing foam cell formation in human monocyte-⁎ Corresponding author. Tel.: +44 20 7468 5274; fax: +44 20 7468 5204.
E-mail address: kbotham@rvc.ac.uk (K.M. Botham).
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Open access under CC BY-NC-ND license.derived macrophages (HMDM) [10] and in human and murine
monocyte/macrophages cell lines [11,12].
Low density lipoprotein (LDL) plays a major role in
atherogenesis and in foam cell generation, but oxidation of
the lipoprotein particles, a process which can occur within the
artery wall, is necessary before extensive lipid accumulation is
induced [13]. In striking contrast, CMR do not require prior
oxidation to cause macrophages to form foam cells [10–12].
However, our studies have demonstrated that incorporation of
lipophilic antioxidants into the particles enhances, rather than
inhibits, lipid uptake and accumulation in the cells [14,15],
suggesting that the oxidative state of CMRs may play a role in
their induction of foam cell formation, but in the opposite way
to that of LDL. Oxidized CMR could occur either in the artery
wall by the action of the cell-associated lipoxygenase and
myeloperoxidase which are believed to oxidize LDL, or in the
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when fat is cooked at high temperatures, have been shown to be
transported in these lipoproteins [16,17]. Clearly, therefore, it is
important for the understanding of the atherogenicity of CMR to
establish how their oxidation influences their uptake and
induction of foam cell formation and the pathways by which
CMR are internalised by the cells.
It has been demonstrated that CMR are taken up by the liver
by apolipoprotein E (apoE)-dependent pathways mediated by
the LDL receptor (LDLr) and the LDL receptor-like protein
(LRP) [1]. The exact mechanisms by which CMR are taken up
by macrophages, however, are not yet definitively established,
and nothing is known about the effects of oxidation of the
particles on the routes by which they are internalised. The LDL
receptor (LDLr) appears to play a part [1], but as it is down-
regulated by the influx of cholesterol into cells, native LDL
does not induce foam cell formation [16], and our studies [18]
have suggested that the delivery of cholesterol to macrophages
by CMR has a similar effect. Thus, other mechanisms are also
likely to be involved, and evidence from experiments using
antibodies to the LDLr and animals lacking the LDLr supports
this view [10]. Candidates include the LRP [19], the apoB48
triacylglycerol-rich lipoprotein receptor (apoB48r) [20], an as
yet unidentified 43 kDa protein described by Elsegood et al.
[21] and scavenger receptors such as scavenger receptor A (SR-
A) and CD36 [1]. Phagocytosis has also been suggested as a
possible mechanism [22]. Since the route of uptake of LDL by
macrophages is profoundly changed after oxidation from the
regulated LDLr to the unregulated scavenger receptors [16], it is
important to establish whether the oxidative state also alters the
mechanisms of uptake of CMR by the cells.
The aim of this study is to investigate the effects of the
oxidative state of CMR on their uptake by macrophages and on
the accumulation of lipid within the cells, and to determine how
oxidation affects the pathways involved in the internalisation of
the particles. Chylomicron remnant-like particles (CRLPs) at
three different levels of oxidation (CRLPs, oxidized CRLPs
(oxCRLPs) and CRLPs containing the antioxidant probucol
(pCRLPs)) and macrophages derived from the human monocyte
cell line THP-1 were used as the experimental model, and the
mechanisms of uptake were evaluated using specific inhibitors
of the processes believed to be involved. The findings clearly
demonstrate that oxidation of CRLPs reduces the rate of their
uptake by THP-1 macrophages and decreases lipid accumula-
tion in the cells, and further show that this is due to differential
interaction with apoE dependent receptors.
2. Materials and methods
RPMI 1640 medium, fetal bovine serum (FBS), L-alanyl-L-glutamine
(glutamax) penicillin/streptomycin and β-mercaptoethanol were obtained from
Gibco (Paisley, UK). FBS was heat inactivated (56 °C, 30 min) before use.
Trypan blue, fatty acid-free bovine serum albumin (BSA), phospholipids,
cholesterol, cholesteryl oleate, phorbol 12-myristate 13-acetate (PMA), Oil red
O, probucol, poly inosinic acid (poly I), lactoferrin and cytochalasin D were
supplied by Sigma (Poole, UK). 1′1′-dioctadecyl-3,3-3′,3′-tetramethylindo-
carbocyanide perchlorate (DiI) was from Cambridge Bioscience (Cambridge,
UK). The blocking antibody for CD36 was obtained from Immunodiagnostic
Systems Ltd (Tyne and Wear, UK) and cholesterol oxidase from MerckBiosciences Ltd (Nottingham, UK). DiI-labelled acetylated LDL (acLDL) was
purchased from Molecular Probes (Paisley, UK).
2.1. Preparation of lipoproteins
LDL and high density lipoprotein (HDL) were isolated from human plasma
(National Blood Service, London UK) by ultracentrifugation. Plasma was layered
under 0.9%NaCl (d=1.006 g/ml), centrifuged for 5 h at 100,000×g (4 °C), and the
top fraction discarded. The density of the bottom layer was raised to 1.063 g/ml
with KBr, layered under KBr (d=1.063 g/ml) and centrifuged for 16 h at
175,000×g (4 °C). LDL was collected from the top fraction by tube slicing. For the
preparation of HDL, the bottom fraction was then adjusted tod 1.21 g/ml with KBr,
layered under KBr (d 1.21 g/ml) and centrifuged at 175,000×g/ml at 4 °C for 18 h
and the top fraction containing HDL was collected by tube slicing. LDL and HDL
were dialysed against saline for 48–72 h prior to used.
CRLPs were prepared by sonication (power setting 22–24 μm, 20 min, at
56 °C) of a lipid mixture containing 70% trilinolein, 2% cholesterol, 3%
cholesteryl ester and 25% phospholipids in 0.9% NaCl (w:v) in Tricine Buffer
(20 mM, pH 7.4) followed by stepwise density gradient (2.5 ml d 1.065 g/ml,
2.5 ml d 1.020 g/ml, 3 ml d 1.006 g/ml) ultracentrifugation as described by
Diard et al. [23] at 17,000×g for 20 min at 20 °C. The upper layer of grossly
emulsified lipids was then removed and replaced with an equal volume of NaCl
solution (d=1.020 g/ml) and tubes were centrifuged at 70,000×g for 1 h (20 °C).
For apoE binding, lipid particles collected from the top layer were incubated
with the dialysed d 1.063–1.21 g/ml fraction of human plasma (National Blood
Transfusion Service, North London Centre, UK) prepared as described above at
37 °C with shaking for 4 h (1 volume of particles: 2 volumes plasma). The
CRLPs containing apoE were then isolated by ultracentrifugation at
d=1.006×g/ml (120,000×g for 12 h at 4 °C), harvested from the top layer,
purified by a second centrifugation at the same density (202,000×g for 4 h at
4 °C) and stored at 4 °C under argon until required. All preparations were used
within 1 week. For DiI-labelled CRLPs and pCRLPs, probucol (1 mg) and/or
DiI were added to the lipid mixture prior to sonication. CRLPs were oxidized by
incubation with CuSO4 (20 μM) with shaking for 5 h at 37 °C and the CuSO4
was then removed by dialysis (0.9% NaCl, 24 h, 4 °C). The oxidation process
had no effects on the fluorescent properties of the DiI label.
2.2. Culture of THP-1 cells
THP-1 monocytes were maintained in RPMI 1650 culture medium
containing 10% (v/v) FBS, glutamax (2 mM), penicillin/streptomycin (100 U/
ml/100 μg/ml) and β-mercaptoethanol (20 μM) (culture medium). The cells
were differentiated into macrophages by incubation with PMA (200 ng/ml) for
72 h at 37 °C in 5% CO2/95% air. The medium containing PMA and any non-
adherent cells were then removed and the macrophages were washed with PBS
(3×1 ml) and incubated with CRLPs or DiI-labelled CRLPs (30 μg cholesterol/
ml) in the presence or absence of specific inhibitors as indicated in the text. The
inhibitors were added 1 h prior to the addition of the CRLPs. Cell viability as
assessed by Trypan blue exclusion was N95% and was not affected by any of the
CRLP types or conditions used. After the incubation, the macrophages were
washed (culture medium 3×1 ml) and lipid accumulation was assessed by
staining with Oil red O, or harvested for lipid analysis [24]. For studies with DiI-
labelled CRLPs, the fluorescence associated with the cells was assessed by
viewing with a Zeiss LMS 510 laser -scanning confocal microscope and
quantified by absorbance volume analysis, or by fluorescence-activated cell
analysis (FACS) using a BD FACS Calibur flow cytometer (BD Biosciences,
Oxford, UK). For FACS analysis, cells were harvested in PBS containing EDTA
(5 mM) and lidocaine -HCl (8 mg/ml), incubated for 20 min at 37 °C and
centrifuged at 10,000×g (2 min). The cell pellet was then resuspended and fixed
in PBS containing 4% formalin.
2.3. Analytical methods
For mRNA analysis, total RNA was extracted from THP-1 macrophages
before or after incubation with CRLPs (30 μg cholesterol/ml) using a kit from
Sigma (Poole, UK) and first strand synthesis was carried out using a kit supplied
by Promega (Southampton, UK) according to the manufacturer's instructions.
Table 1
Primer sequences and product sizes (bp) for RT-PCR
Gene Forward primer Reverse primer Product size
LDLr TGAAGTTGGCTGCGTTAATGTG CATTCGCCGCTGTGACACT 70
LRP GGTACTACCTGCGCAAGCTC CACATTGCTCCCGTTAAGGT 123
GAPDH AGAACATCATCCCTGCCTCTACT GATGTCATCATATTTGGCAGGTT 110
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phosphate dehydrogenase (GAPDH) were determined by real time polymerase
chain reaction using a SYBR green quantitative PCR kit (Sigma, Poole, UK)
with an Opticon light cycler under the following conditions; denaturation at
94 °C for 2 min followed by 40 cycles of 94 °C for 15 s, 58 °C for 1 min, with a
final extension at 72 °C for 1 min. The primers used and the product sizes are
shown in Table 1. The Ct values were determined by automated threshold
analysis using Opticon Monitor 2 software. Data were normalized with the
values obtained for GAPDH and the fold change in mRNA expression in CRLP-
treated as compared to untreated macrophages was determined by the method
described by Pfaffl [25].
Lipids were extracted from cell samples by the addition of chloroform:
methanol (2:1 v:v, 20 volumes) followed by 0.88% KCl (v:v) (40% total
volume). The mixture was shaken and the chloroform layer containing the lipids
was collected and dried under nitrogen. The triacylglycerol (TG) content of
CRLPs and lipid extracts was determined using a fully enzymatic assay kit
(Alpha Laboratories, Eastleigh, Hants, UK) in which glycerol released from
triacylglycerol by a lipase is measured using glycerol phosphate oxidase and
peroxidase. The total cholesterol (cholesterol+cholesteryl ester) content of
CRLPs and lipid extracts was determined using cholesterol oxidase and
cholesteryl esterase (kit supplied by Sigma, Poole, UK), and the cholesterol
content of lipid extracts was determined enzymatically using cholesterol oxidase
[26]. Cholesteryl ester concentrations were calculated by subtracting the values
for cholesterol from those for total cholesterol. The extent of oxidation of
CRLPs was determined by measuring the level of thiobarbituric acid-reacting
substances (TBARS) in the preparations [27].
The apolipoprotein content of CRLPs was assessed by SDS-PAGE using
10% gels [28]. Proteins were visualised by staining with Coomassie blue and the
bands corresponding to apoEwere quantified by optical density volume analysis.
Significance limits were calculated using ANOVA repeated measures or one
way ANOVA followed by Student's paired t test for experiments with multiple
time points or a single time point, respectively, except where indicated otherwise.
3. Results
3.1. Characteristics of CRLPs
The lipid composition of CRLPs, oxCRLPs and pCRLPs is
shown in Table 2. The concentration of TG and TC in CRLPs
and pCRLPs was similar, but that of oxCRLPs was a littleTable 2
Lipids and TBARS content of CRLPs
Parameter CRLPs oxCRLPs pCRLPs
TC (μmol/ml) 0.86±0.12(23) 0.70±0.11(23) 0.89±0.04(19)
CE (μmol/ml) 0.77±0.20(23) 0.48±0.29(23) 0.85±0.03(19)
UC (μmol/ml) 0.13±0.04(23) 0.12±0.07(23) 0.04±0.01(19)
TG (μmol/ml) 4.79±0.36(23) 3.41±0.50(23) 4.12±0.20(19)
TG:TC 5.93±0.07(23) 4.96±0.08(23) 4.96±0.63(19)
TBARS (nmol MDA/
μmol TG)
0.99±0.14(23) 7.52±3.03(23)** 0.38±0.26(19)*
CRLPs were prepared as described in Materials and methods and their
triacylglycerol (TG), cholesteryl ester (CE), unesterified cholesterol (UC), total
cholesterol (TC) and TBARS content was determined. Data shown are the
mean±SEM (number of preparations). *Pb0.05, **Pb0.01 vs. CRLPs (one-
way ANOVA, Bonferroni's test post hoc).lower, reflecting the dilution of the preparations during the
oxidation procedure. The mean TG:TC ratio, however, was
between 5 and 6 for all 3 CRLP types. Previous work in our
laboratory has shown that the phospholipid content of CRLPs,
oxCRLPs and pCRLPs prepared by the methods used here are
not significantly different [15,29]. Analysis of the TBARS
content of the particles showed that there were significant
differences in their oxidative states, with values being higher in
oxCRLPs as compared to CRLPs, while those for pCRLPs were
lower (one way ANOVA, Bonferroni's test post hoc) (Table 2).
The apoE content of CRLPs, oxCRLPs and pCRLPs was
evaluated by SDS PAGE electrophoresis. The results showed that
the particles contained apoE, but no apoE was detected in the top
fraction of the d 1.063–1.21 g/ml fraction of human plasma
incubated and centrifuged in the absence of lipid particles
(Fig. 1A), indicating that the apoprotein was bound to the CRLPs
during the incubation. No apoCs or other apolipoproteins were
detectable. There were no significant differences in the apoEFig. 1. CRLPs were prepared as described in Materials and methods, the proteins
were extracted and separated by SDS PAGE electrophoresis and the gels were
stained with Coomassie blue. (A) Lane 1 CRLPs; lane 2, oxCRLPs; lane 3,
pCRLPs; lane 4, molecular weight markers; lane 5, plasma incubated without
lipid particles. (B) Optical density volume analysis of the bands corresponding
to apoE (molecular weight 34,000) for CRLPs, oxCRLPs and pCRLPs. Data
shown are the mean from 3 separate preparations in each case and error bars
show the SEM.
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optical density volume analysis (Fig. 1B).
3.2. Effect of the oxidative state of CRLPs on the induction of
lipid accumulation in macrophages
Incubation of THP-1 macrophages with CRLPs or oxCRLPs
for 5,24 or 48 h caused a marked increase in the total lipid found
in the cells (Fig. 2A) at all time points, but lipid accumulation
was greater with CRLPs as compared to oxCRLPs (Pb0.001).
This effect was mainly due to greater accumulation of TG in theFig. 2. THP-1 macrophages were incubated in the absence (control) or presence
of CRLPs or oxCRLPs (30μg cholesterol/ml) for the times indicated and the
lipid content of the cells was determined. (A) Total lipid (TG+TC); (B)
triacyglycerol (TG); (C) total cholesterol (TC). Data shown are the mean from 4
separate experiments. Error bars show the SEM. Total lipid and TG, CRLPs vs.
oxCRLPs, Pb0.001 (ANOVA repeated measures).presence of CRLPs (Pb0.001) (Fig. 2B), as the trend for an
increase in TC in CRLP- as compared to oxCRLP-treated
macrophages did not reach significance (Fig. 2C).
3.3. Effect of the oxidative state of CRLPs on their uptake by
macrophages
The uptake of DiI-labelled CRLPs, oxCRLPs and pCRLPs
by THP-1 macrophages was assessed by confocal microscopy
and FACS analysis (Fig. 3). Examination of cells incubated with
DiI-labelled particles for periods up to 24 h with the confocal
microscope showed that the fluorescence associated with the
cells increased with time in all cases, but that there was clearly
more in pCRLP- and less in oxCRLP-treated as compared to
CRLP-treated cells (Fig. 3A). Quantification of the cell-
associated fluorescence and analysis by ANOVA repeated
measures showed that the rate of uptake of CRLPs over 24 h
was significantly higher than that of oxCRLPs (Pb0.01) and
significantly lower than that of pCRLPs (Pb0.01) (Fig. 3B),
and a similar result was obtained using FACS (Pb0.05, CRLPs
vs. oxCRLPs or pCRLPs (Fig. 3C).
3.4. Role of apoE in the uptake of CRLPs of different oxidative
states
To investigate whether apoE is necessary for uptake of
CRLPs, THP-1 macrophages were incubated with DiI-labelled
CRLPs or CRLPs without apoE for 2 h and the fluorescence
associated with the cells was determined by FACS analysis. In
the absence of apoE, the uptake of CRLPs was reduced by about
90% (fluorescence values: CRLPs, 98.6±7.1; CRLPs without
apoE, 8.4±0.9, n=3).
The potential role of apoE dependent receptors in the uptake
of CRLPs by the cells was studied using excess LDL and the
LRP ligand, lactoferrin, to block entry via the LDLr and LRP,
respectively. The effects of lactoferrin (2 mg/ml) on lipid
accumulation in macrophages exposed to CRLPs or oxCRLPs
as assessed by Oil red O staining are shown in Fig. 4. Lacto-
ferrin had no effect on the lipid content of cells incubated in the
absence of CRLPs, but reduced that in macrophages treated
with either CRLPs or oxCRLPs (Pb0.05, both cases).
When the effects of excess LDL (200 μg cholesterol/ml)
and lactoferrin (2 mg/ml), on the fluorescence associated with
the macrophages after incubation for 1, 4, 16 and 24 h with
CRLPs, oxCRLPs or pCRLPs were assessed by confocal
microscopy (Fig. 5A–C), no significant inhibition was
observed in the presence of excess LDL, but lactoferrin
caused a decrease of N90% in experiments with CRLPs (Fig.
5A) and oxCRLPs (Fig. 5B) and N80% with pCRLPs (Fig.
5C) (Pb0.0001, all cases). Addition of LDL and lactoferrin
together completely abolished detectable uptake of all three
types of particles (Fig. 5A–C). FACS analysis of macro-
phages treated with CRLPs, oxCRLPs or pCRLPs in the
presence or absence of lactoferrin (2 mg/ml), LDL (300 μg
cholesterol/ml) or LDL+lactoferrin for 2 h also showed that
lactoferrin caused a marked decrease of about 75% in the
uptake of all three types of CRLPs (Pb0.01), and in this case
Fig. 3. DiI-labelled CRLPs, oxCRLPs or pCRLPs (30 μg cholesterol/ml) were incubated with THP-1 macrophages for times up to 24 h and cell-associated
fluorescence was evaluated by confocal microscopy or FACS. (A) Confocal microscopy images after 16 h incubation; (B) uptake of fluorescence by the cells over 24 h
as assessed by confocal microscopy; (C) uptake of fluorescence by the cells over 6 h as assessed by FACS. Each point (B and C) is the mean from 3 experiments. Error
bars show the SEM. Significance limits: B (confocal microscopy), CRLPs vs. oxCRLPs or pCRLPs, Pb0.01; C (FACS), CRLPs vs. oxCRLPs or pCRLPs, Pb0.05
(ANOVA repeated measures).
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presence of LDL (Pb0.05) (Fig. 5D). Moreover, in a further
separate experiment in which the excess of LDL added was
increased by lowering the concentration of CRLPs to 10 μgFig. 4. THP-1 macrophages were incubated without (control) or with CRLPs or oxC
48 h. The cells were then stained with Oil red O and the staining density was measured
vs. CRLPs+ lactoferrin, oxCRLPs vs. oxCRLPs+ lactoferrin, Pb0.05 (ANOVA repecholesterol/ml and raising that of LDL to 500 μg cholesterol/
ml, the uptake of both CRLPs and oxCRLPs was also
significantly inhibited (fluorescence values (n=3): CRLPs,
94.8±6.2; CRLPs+ LDL, 58.7±5.8 (Pb0.05); oxCRLPsRLPs (30 μg cholesterol/ml) in the presence of lactoferrin (2 mg/ml) for 5, 24 or
. Data shown are the mean from 4 experiments. Error bars show the SEM. CRLPs
ated measures).
Fig. 6. DiI-labelled acetylated LDL (acLDL) (10 μg cholesterol/ml) was incubated
with THP-1 macrophages in the presence or absence of excess LDL (500 μg
cholesterol/ml), lactoferrin (LF) (2 mg/ml) or poly I (50 μg/ml) for 2 h after pre-
incubation with the inhibitors for 30 min, and cell-associated fluorescence was
evaluated by FACS. Data shown are the mean from 3 separate experiments and
error bars show the SEM. *Pb0.05 vs. acLDL (one-way ANOVA).
Fig. 5. DiI-labelled CRLPs, oxCRLPs or pCRLPs (30 μg cholesterol/ml) were incubated with THP-1 macrophages in the presence/absence of LDL and/or lactoferrin
and cell-associated fluorescence was evaluated by confocal microscopy after 1, 4, 16 or 24 h (A, CRLPs; B, oxCRLPs; C, pCRLPs) or by FACS after 2 h (D). Data are
the mean from 3 experiments and error bars show the SEM. Confocal microscopy: CRLPs vs. CRLPs+ lactoferrin or+LDL+lactoferrin, oxCRLPs vs. oxCRLPs+
lactoferrin or+LDL+lactoferrin, pCRLPs vs. pCRLPs+lactoferrin or+LDL+lactoferrin, Pb0.0001 (ANOVA repeated measures): FACS; *Pb0.05, **Pb0.01 vs.
corresponding no additions (one way ANOVA).
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in the experiments using confocal microscopy, adding both LDL
and lactoferrin to the incubations caused a further decrease to
similar minimal levels in the uptake of all three types of CRLPs.
Assessment of the fluorescence associated with THP-1
macrophages after incubation with DiI-labelled acetylated LDL
(acLDL) (10 μg cholesterol/ml) for 2 h showed that acLDL
uptake, in contrast to that of CRLPs, was not significantly
inhibited by excess LDL (500 μg cholesterol/ml) or lactoferrin
(2 mg/ml) (Fig. 6).
3.5. Role of scavenger receptors and phagocytosis in the
uptake of CRLPs of different oxidative states
The effects of blocking the class A scavenger receptor SR-A,
the class B receptors CD36 and SR-B1 or phagocytosis on the
uptake of CRLPs by THP-1 macrophages was investigated
using poly-I, a known ligand for SR-A, a blocking antibody to
CD36, excess HDL, which binds to SR-B1, and cytochalasin D,
which blocks the polymerization of actin microfilaments [30].
Evaluation of the fluorescence associated with the cells after
incubation with DiI-labelled CRLPs, oxCRLPs or pCRLPs for
1, 4,16 or 24 h by confocal microscopy (Fig. 7A–C) show no
significant change in the presence of poly-I (5 μg/ml) or excessHDL (300 μg/ml). Significant decreases, however, were
observed in the presence of anti-CD36 (1 μg/ml) (−38% after
24 h) (Pb0.05) and cytochalasin D (10 μg/ml) (−27% after
24 h) (Pb0.01) in experiments with CRLPs (Fig. 7A), although
no change in the uptake of oxCRLPs or pCRLPs was detected
with these treatments (Fig. 7B, C).
FACS determinations after incubation of macrophages with
CRLPs, oxCRLPs or pCRLPs for 2 h confirmed that poly-I and
HDL did not inhibit the uptake of the particles (Fig. 7D).
Fig. 7. DiI-labelled CRLPs, oxCRLPs or pCRLPs (30 μg cholesterol/ml) were incubated with THP-1 macrophages in the presence/absence of poly I, excess HDL, anti-
CD36 or cytochalasin D and cell-associated fluorescence was evaluated by confocal microscopy after 1, 4, 16 or 24 h (A, CRLPs; B, oxCRLPs; C, pCRLPs) or by
FACS after 2 h (D). Data are the mean from 3 experiments and error bars show the SEM. Confocal microscopy, CRLPs vs. CRLPs+anti CD36 or+cytochalasin D,
Pb0.05 (ANOVA repeated measures). FACS, *Pb0.05 vs. corresponding no additions (one way ANOVA).
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decreased by about 90% in the presence of poly-I (50 μg/ml)
(Fig. 6). As found in the experiments using confocal microscopy,
anti-CD36 and cytochalasin D significantly inhibited the uptake
of CRLPs, but in this case effects of a similar magnitude were
also seen with oxCRLPs and pCRLPs (After 24 h:anti-CD36;
CRLPs, −38%, oxCRLPs −40%, pCRLPs, −39%: cytochalasin
D; CRLPs −39%, oxCRLPs −35%, pCRLPs −38%), although
the changes with oxCRLPs did not reach significance (Fig. 7D).
3.6. Expression of mRNA for the LDLr and LRP in THP-1
macrophages
In THP-1 macrophages exposed to CRLPs (30 μg choles-
terol/ml) for 24 h, LRP mRNA levels were increased in CRLP-
treated THP-1 cells (fold change, 2.7±1.01, n=3), while LDLr
mRNA abundance was decreased (0.27±0.11(range), n=2).
4. Discussion
Since homogeneous CMR cannot be obtained easily from
human blood without contamination with other lipoproteins of a
similar density such as chylomicrons and very low density
lipoprotein (VLDL), model CRLPs were used in this study.
These particles are similar in size, density and lipid composition
to physiological remnants [23], and also contained human apoE,thus they differ from physiological CMR only in lacking
apoB48. Importantly, extensive previous studies in both humans
and experimental animals have demonstrated that chylomicron-
and chylomicron remnant-like particles without apoB48 are
cleared from the blood and metabolised in a similar way to the
corresponding physiological lipoproteins [31–34]. In addition,
CRLPs lacking apoB48, but containing apoE from the
appropriate species, have been found to have effects which
mimic those of physiological remnants in rat hepatocytes and
pig endothelial cells [23,35], and our earlier work has shown
that CRLPs cause extensive lipid accumulation in THP-1
macrophages and human monocyte derived macrophages
(HMDM) which is comparable to that found in experiments
with physiological CMR from rats and the murine macrophage
cell line J774 [24,36]. For the current investigation, the use of
CRLPs facilitated the manipulation of the oxidative state of the
particles by inclusion of the lipophilic antioxidant probucol or
by exposure to oxidising conditions similar to those used
extensively in studies with oxLDL [16]. In previous work, we
have shown that incorporation of probucol into CRLPs
increases their uptake by THP-1 macrophages [15], and that
this is due to protection of the particles from oxidation, since
lycopene, a chemically unrelated antioxidant, has a similar
effect [14]. For the present study, therefore, we used pCRLPs in
addition to CRLPs and oxCRLPs, so that 3 different oxidative
states were tested. Assessment of TBARS in the particles used
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pCRLPs were significantly different, and there were no
significant differences in their apoE content, thus they provided
a convenient and suitable model for the study.
Earlier work in our laboratory and others has demonstrated
that CMR cause the extensive lipid accumulation associated
with foam cell formation in HMDM, THP-1 macrophages and
murine macrophage cell lines [24,36,37]. In experiments with
THP-1 macrophages and HMDM, we found that CRLPs
induced a greater increase in the intracellular total lipid content
than oxLDL (at the equivalent cholesterol level), and that, as
might be expected, this was mainly due to greater accumulation
of TG, while TC levels were raised to a comparable extent with
both types of lipoprotein [24]. In the current study we compared
the effects of oxidized and non-oxidized particles and, although
both caused rises in cellular lipid content compared to untreated
cells, the increase was clearly smaller with oxCRLPs as
compared to CRLPs, mainly because of decreased accumulation
of TG (Fig. 2). These results suggest that the uptake of CRLPs
by the cells may be inhibited by oxidation, and this was
confirmed in confocal microscopy and FACS studies (Fig. 3),
which showed that the rate of uptake of CRLPs was decreased
by oxidation and increased by incorporation of probucol into the
particles to protect them from oxidation (Table 2). These results
clearly demonstrate that oxidation of CMR inhibits their uptake
by macrophages and attenuates foam cell formation. This is an
important new finding, since this effect is strikingly different
from that found with LDL, where oxidation is required to
induce macrophages to form foam cells.
CMR are known to be cleared from the circulation by the
liver mainly by apoE-dependent pathways involving the LDLr
and the LRP, and the present study shows that apoE also plays
an important role in the entry of CRLPs into THP-1
macrophages, since a markedly reduced rate of uptake was
observed when apoE was not present in the particles. These
finding are in agreement with earlier work which has suggested
that both the LDLr and the LRP are involved in the uptake of
CMR by macrophages [10,19,38]. Our results indicate that both
receptors are able to mediate the uptake of CRLPs regardless of
their oxidative state, although lactoferrin, a ligand for the LRP,
caused a marked reduction in lipid accumulation and uptake
after exposure of THP-1 macrophages to all three types of
CRLPs (Figs. 4, 5), while the maximum effect of excess LDL
on uptake observed was more modest in all cases (Fig. 5). This
lesser role of the LDLr may be due to its down-regulation on the
influx of lipoprotein into cells. We have shown previously that
the expression of mRNA for the LDLr in THP-1 macrophages is
decreased by CRLPs while the expression of LRP mRNA is
increased [18], and the present study, which shows a decrease of
about 73% in LDLr mRNA and a 2.7fold rise in LRP mRNA
after exposure of the macrophages to CRLPs, is in agreement
with these findings.
The differences in rates of uptake of oxCRLPs, CRLPs and
pCRLPs were retained in the presence of inhibitors of both the
LDLr and the LRP, although when both the LDLr and the LRP
were blocked, uptake of oxCRLPs, CRLPs and pCRLPs was
reduced to a similar low level (Fig. 5), suggesting that thedifference in their rate of uptake is apoE-dependent. Thus, an
important novel finding of this study is that oxidation of
CRLPs, unlike LDL, does not change their major routes of
uptake by macrophages, with apoE-dependent receptors being
of major importance and the LRP playing the predominant
role, regardless of the oxidative state of the particles. ApoE
does not bind to the LDLr family in its lipid-free state, as
interaction with lipid is necessary to induce a conformational
change which promotes high affinity for the receptors [39]. In
addition, apoE has been shown to adopt different conforma-
tions when complexed to different lipids. Thus, changes in the
lipid composition of lipoproteins such as an increased content
of oxidized lipids or the presence of lipophilic compounds such
as probucol may alter the conformation of the protein on their
surface, and not all apoE molecules on a particular remnant
particle may be able to act as ligands [39,40]. The different
rates of uptake of CRLPs oxCRLPs and pCRLPs by
macrophages demonstrated here, therefore, could be explained
by effects on interaction with the LDLr and the LRP caused by
differences both in the conformation of apoE and in the
number of apoE molecules able to bind to the receptors, even
though the total amount of apoE associated with the particles is
not changed. Although we cannot rule out the possibility that
the faster internalization of pCRLPs is due a specific effect of
probucol on the surface structure of the particles, the finding
that CRLPs are taken up more slowly after oxidation and more
rapidly when the antioxidant is present suggests the changes
are more likely to be related to the amounts of oxidized lipid in
the particles.
The expression of scavenger receptors such as SR-A and the
class B receptors CD36 and SR-B1 is a characteristic feature of
macrophages, and SR-A and CD36 are know to play a part in the
induction of foam cell formation by oxidized or chemically
modified LDL [41]. It is possible, therefore, that this type of
receptor may also be involved the uptake of oxCMR by macro-
phages. In the present study, poly I, a ligand for SR-A, reduced the
uptake of acLDL by THP-1 cells by about 90% as expected, but
had no significant effect on the uptake of CRLPs, irrespective of
their oxidative state. In addition, excess HDL, which binds to SR-
B1, did not prevent the entry ofCRLPs, oxCRLPs or pCRLPs into
the cells. In contrast, in the presence of anti-CD36, the uptake of
all three CRLP types was inhibited by about 35–40% so that the
differences in their rates of uptake were retained (Fig. 7). Thus,
SR-A and SR-B1 do not appear to play a significant part in the
uptake of oxCRLPs bymacrophages, although CD36may have a
role which is unaffected by the oxidative state of the particles.
Mamo et al. [22] have reported previously that the pha-
gocytosis may be important in the uptake of CMR by rabbit
alveolar macrophages, although in a later electron microscopy
study with HMDM they found no evidence for entry via this
route [42]. In our experiments with THP-1 macrophages,
however, cytochalasin D inhibited the uptake of all CRLPs
types tested by 35–40%, suggesting that some phagocytosis of
CRLPs of all oxidative states does occur in these cells (Fig. 7).
It has been suggested that the apoB48r may be involved in
the uptake of chylomicron remnants by macrophages [1,20],
and Kawakami et al. [43] have reported that it is responsible for
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lipoproteins from hyperlipidemic patients. Since apoB48 is an
integral protein incorporated during the assembly of chylomi-
crons in intestinal cells, it is not possible to bind it to model
CRLPs in a physiological way. The particles used in the present
work, therefore, do not contain apoB48 and we were unable to
study involvement of this receptor in the uptake of CMR by
macrophages. However, antibodies to apoB48 have been found
not to inhibit the uptake of chylomicron remnants by rat
macrophages [44], and Elsegood et al. [21] who were unable to
detect binding of chylomicron remnants to a protein with a
molecular weight corresponding to the apoB48 receptor in
THP-1 macrophages have suggested that it may be specific for
VLDL remnants rather than chylomicron remnants.
The results of this study demonstrate that oxidative modifica-
tion of CMR as compared to LDL has profoundly different effects
on the uptake of the particles and the subsequent induction of lipid
accumulation in macrophages. Instead of markedly enhancing
foam cell formation, oxidation of CMR slows their uptake by
macrophages and reduces the amount of lipid subsequently
accumulated in the cells. This difference may be due to the
different receptor mechanisms involved, since oxidation of LDL
shifts the main route of uptake from the regulated LDLr to the
unregulated scavenger receptors, while our experiments suggest
that CMR are taken up mainly by the LRP with some contribution
from the LDLr, with CD36 and phagocytosis playing only minor
roles, irrespective of their oxidative state. These findings provide
important new information about the way in which oxidation of
CMR influences their induction of foam cell formation and the
mechanisms involved, and has important implications for the role
of dietary factors such as oxidized lipids and antioxidants which
are transported in CMR in the promotion of atherosclerosis.
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